British Pharmacopoeia 2027 Edition

Product Description

British Pharmacopoeia 2027

New, legally enforced standards available from 1 August 2026. The BP 2027 edition supersedes the BP 2026 and becomes legally effective on 1 January 2027.

Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.

It includes approximately 4,000 monographs, which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.

All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and internationally.

New for the BP 2027

The BP 2027 supersedes the BP 2026 and becomes legally effective on 1 January 2027. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.

Monographs and BPCRS:

• 18 new BP monographs and all new texts added with Issues 12.1 to 12.3 of the Ph. Eur.
• One new infrared reference spectrum has been added to the collection
• 13 new BPCRS
• 131 amended BP monographs
• 132 amended BP texts

Multi-user online licence = POA

Flexible annual multi-user access options are available to suit every need – from licences that allow unlimited users within one country to share access (within licence restrictions), to global licences and academic licences for wider availability. For more information on these licenses, call or email.

ISBN: 9780113231157 &  9780113231140